Singular Genomics Systems Inc (OMIC)
21.90
+0.22
(+1.01%)
USD |
NASDAQ |
Nov 21, 16:00
21.45
-0.45
(-2.05%)
Pre-Market: 20:00
Singular Genomics Systems Gross Profit Margin (Quarterly): -74.14% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -74.14% |
| June 30, 2024 | -24.15% |
| March 31, 2024 | -94.80% |
| December 31, 2023 | -42.28% |
| Date | Value |
|---|---|
| September 30, 2023 | -14.07% |
| June 30, 2023 | -18.22% |
| March 31, 2023 | 6.49% |
| December 31, 2022 | -3.14% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-94.80%
Minimum
Mar 2024
6.49%
Maximum
Mar 2023
-33.04%
Average
-21.18%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Bruker Corp | 48.45% |
| Azenta Inc | 40.82% |
| Harvard Bioscience Inc | 58.10% |
| Bionano Genomics Inc | -139.1% |
| Akoya Biosciences Inc | 62.32% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -54.24% |
| Return on Assets | -36.10% |
| Return on Invested Capital | -51.76% |
| Profit Margin (Quarterly) | -4.14K% |
| Operating Margin (Quarterly) | -4.45K% |
| Return on Net Operating Assets | -83.99% |